The R&D team at Inga has developed expertise
in pharmaceutical research with competencies developed in analytical
method validation, scale-up batch manufacturing, bio-equivalence
studies, validation studies and commercial batch manufacturing.
Currently the team is involved in the development of a number of
immediate release and sustained release formulations. Products are
also being developed utilizing alternate routes of drug delivery
(topical and transdermal products).
The above research has facilitated the creation
of experienced teams to carry out solubility studies, partition
co-efficient studies, pKa determination, polymorphism studies, stability
studies, isolation and identification of impurities and degradation
products, stress modelling for drug substances and formulations